Navigation Links
NuMedii, Inc. Announces New Indications Discovery Collaboration With Astellas
Date:1/11/2016

PALO ALTO, Calif., Jan. 11, 2016 /PRNewswire/ -- NuMedii, Inc. today announced the formation of a discovery collaboration with Astellas Pharma Inc. ("Astellas") to identify new indications for a number of undisclosed Astellas compounds using NuMedii's predictive Big Data intelligence technology.

"NuMedii's predictive Big Data intelligence technology enables the discovery of new uses for both marketed drugs and shelved development assets across a number of therapeutic areas," stated Asim Siddiqui, Ph.D., chief technology officer, NuMedii, Inc. "We are excited to partner with Astellas to explore new indications for a number of their assets which we hope will be of benefit to patients in need and the physicians who treat them."

This is NuMedii's second collaboration with a large pharmaceutical company in recent months. In September 2015, the Company announced a partnership with Allergan for discovery of new treatments for psoriasis.

The Company's proprietary and dynamic Big Data intelligence technology consists of hundreds of millions of human, biological, pharmacological and clinical data points that NuMedii has normalized and annotated. NuMedii integrates these data with proprietary network-based algorithms to find both drug candidates and biomarkers predictive of efficacy for diseases. In 2013, NuMedii entered into a strategic technology partnership with the Intellectual Property and Life Science business of Thomson Reuters, creating an unprecedented repository of methodologies and content to systematically identify new applications for existing drug compounds. NuMedii is initially using its Big Data technology to discover and de-risk new indications for medicines.

Financial terms of the agreement were not disclosed.

About Astellas

Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. We focus on Urology, Oncology, Immunology, Nephrology and Neuroscience as prioritized therapeutic areas while advancing new therapeutic areas and discovery research leveraging new technologies/modalities. We are also creating new value by combining internal capabilities and external expertise in the medical/healthcare business. Astellas is on the forefront of healthcare change to turn innovative science into value for patients. For more information, please visit our website at http://www.astellas.com.

About NuMedii, Inc.

NuMedii, Inc., discovers effective new drugs by translating its predictive data intelligence technology into therapies with a higher probability of therapeutic success. The Company's exclusive Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. NuMedii translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. Headquartered in Palo Alto, California, NuMedii's investors include Claremont Creek Ventures and Lightspeed Venture Partners. For more information, please visit www.numedii.com.

 


'/>"/>
SOURCE NuMedii, Inc.
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. NuMedii, Inc. Announces Research Collaboration with Allergan To Explore New Treatments For Psoriasis
2. Medicure Announces Preliminary Revenue For Fiscal 2015
3. Worlds Largest Materials Science Catalog Announces Launch Of New Website
4. Agena Bioscience Announces the Expansion of its Headquarters in San Diego, California, to Better Serve its Growing Customer Base
5. Nevro Announces Preliminary Unaudited Fourth Quarter and Fiscal Year 2015 Revenue
6. Sorrento Announces Positive Data from Phase 3 studies of Biosimilar Antibodies, STI-001 and STI-002
7. Exact Sciences Announces Preliminary Fourth Quarter and Full Year 2015 Results
8. Exact Sciences Announces Contract with Anthem BlueCross of California
9. IRIDEX Announces Preliminary Unaudited Revenues for 2015 Fourth Quarter and Full Year
10. Accuray Announces Preliminary Second Quarter Financial Results
11. SciClone Announces Preliminary 2015 Revenue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2019)... ... , ... Chlorophyll Water was selected by the Permanent Mission of India to ... , International Day of Yoga, unofficially referred to as Yoga Day, is celebrated ... United Nations General Assembly. , Marking the International Yoga Day, the United Nations held ...
(Date:7/17/2019)... ... July 17, 2019 , ... The American Psychiatric Nurses Association (APNA) is pleased ... Nominating Committee . Elected by psychiatric-mental health nurse members from across the country, these ... in New Orleans, LA, October 2-5, 2019. , “These new members of the Board ...
(Date:7/17/2019)... (PRWEB) , ... July 17, 2019 , ... Eargo ... its rapid expansion with the addition of three new executive hires: CFO Adam Laponis ... Software Engineering, Fernando Cruz (from Rappi, Inc., Apple, Inc.). , The new hires ...
Breaking Medicine Technology:
(Date:7/17/2019)... ... July 17, 2019 , ... Dr. Jonathan Zaidan, MD, FACOG, President of ... Health Woman Show. The show airs on Wednesday, July 17ths at 7pm. ... Dr. Zaidan and co-host Ann Thomas discuss the challenges that women face when it ...
(Date:7/13/2019)... ... 12, 2019 , ... The Oncology Institute of Hope and ... at 5380 S. Rainbow Blvd., Suite 210, Las Vegas, NV 89118. It is ... equipped with state-of-the-art medical equipment plus all of the top-notch care already offered ...
(Date:7/13/2019)... ... July 12, 2019 , ... China Focus @ Bio ... sponsored by Hangzhou Investment Promotion Bureau, Fox Rothschild LLP, MORE Health and Henlius, ... attracted Fosun Pharmaceuticals, WuXi Biologics, Kelun Pharmaceutical, Harbin Pharmaceuticals, Fountain Medical, Luye Life ...
(Date:7/12/2019)... ... July 12, 2019 , ... Rebecca Baxt, M.D., F.A.A.D. and Saida ... Docs for 2019. Located in Paramus, BAXT CosMedical is a renowned facility that believes ... dermatological care for the past 45 years. , NJ Top Docs, Dr. Rebecca Baxt ...
(Date:7/11/2019)... ... July 11, 2019 , ... The Grain Chain, a ... by the American Bakers Association (ABA), testified today on the nutritional benefits of ... recommendations in the Committee’s scientific report, due next year, will form the basis ...
Breaking Medicine News(10 mins):